HCV prevalence in pregnant women in the UK

被引:42
作者
Ades, AE
Parker, S
Walker, J
Cubitt, WD
Jones, R
机构
[1] Inst Child Hlth, Dept Epidemiol & Publ Hlth, London WC1N 1EH, England
[2] Great Ormond St Hosp Children NHS Trust, Dept Virol, London WC1N 3JH, England
[3] Great Ormond St Hosp Children NHS Trust, Dept Clin Biochem, London WC1N 3JH, England
关键词
D O I
10.1017/S0950268899004598
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The objective of the study was to assess the prevalence and epidemiology of hepatitis C virus (HCV) infection in pregnant women in the North Thames region, and in the UK in general. Demographic data were linked to neonatal samples prior to anonymization and testing by anti-HCV EIA, and with RIBA 3 confirmation. Risk factors for maternal infection were explored. Area-specific seroprevalence rates were multiplied into population sizes to estimate HCV prevalence in pregnant women in the UK. A total of 241/126009 samples were confirmed anti-HCV positive. and a further 40 were indeterminate, representing a seroprevalence of 0.19-0.22%; 51% of maternal HCV infections were in UK-born women (71% of the population), and 22% in women from continental Europe (5% of the population). Among European-born women, HCV prevalence was associated with birth in continental Europe, partner not being notified at birth registration, partner born in a different region to the mother, and inner city residence. Four of the 241 anti-HCV positive samples (1.7%) were also anti-HIV-1 positive. It was estimated that each year an estimated 1150 out of 730 000 pregnancies in the UK would involve a woman infected with HCV (uncertainty range 660-1850), a prevalence of 0.16% (0.09-0.25%). On the basis of reported rates of mother-to-child transmission of HCV, this would represent approximately 70 paediatric HCV infections per year.
引用
收藏
页码:399 / 405
页数:7
相关论文
共 31 条
  • [1] Effect of the worldwide epidemic on HIV prevalence in the United Kingdom: record linkage in anonymous neonatal seroprevalence surveys
    Ades, AE
    Walker, J
    Botting, B
    Parker, S
    Cubitt, D
    Jones, R
    [J]. AIDS, 1999, 13 (17) : 2437 - 2443
  • [2] TO C OR NOT TO C - THESE ARE THE QUESTIONS
    ALTER, HJ
    [J]. BLOOD, 1995, 85 (07) : 1681 - 1695
  • [3] Epidemiology of hepatitis C
    Alter, MJ
    [J]. HEPATOLOGY, 1997, 26 (03) : S62 - S65
  • [4] THE PREVALENCE OF HEPATITIS-B AND HEPATITIS-C IN AN ANTENATAL POPULATION OF VARIOUS ETHNIC-ORIGINS
    BOXALL, E
    SKIDMORE, S
    EVANS, C
    NIGHTINGALE, S
    [J]. EPIDEMIOLOGY AND INFECTION, 1994, 113 (03) : 523 - 528
  • [5] PREVALENCE AND EPIDEMIOLOGIC CHARACTERISTICS OF HEPATITIS-C IN SCOTTISH BLOOD-DONORS
    CRAWFORD, RJ
    GILLON, J
    YAP, PL
    BROOKES, E
    MCOMISH, F
    SIMMONDS, P
    DOW, BC
    FOLLETT, EAC
    [J]. TRANSFUSION MEDICINE, 1994, 4 (02) : 121 - 124
  • [6] Routine antenatal screening for hepatitis B using pooled sera: validation and review of 10 years experience
    Cunningham, R
    Northwood, JL
    Kelly, CD
    Boxall, EH
    Andrews, NJ
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1998, 51 (05) : 392 - 395
  • [7] Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
    Davis, GL
    Esteban-Mur, R
    Rustgi, V
    Hoefs, J
    Gordon, SC
    Trepo, C
    Shiffman, ML
    Zeuzem, S
    Craxi, A
    Ling, MH
    Albrecht, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) : 1493 - 1499
  • [8] *DEP HLTH, 1999, UNL AN PREV MON PROG
  • [9] Sexual and perinatal transmission of hepatitis C
    Dienstag, JL
    [J]. HEPATOLOGY, 1997, 26 (03) : S66 - S70
  • [10] GIBB DM, IN PRESS LANCET